Moleculin Announces Grant Awarded to Polish Research Institute for Independent Clinical Trial of Annamycin in Sarcoma Lung Metastases Feb 8, 2021
Moleculin Announces Annamycin Receives FDA Orphan Drug Designation for Soft Tissue Sarcomas Dec 29, 2020
Moleculin Announces FDA Permission to Begin Clinical Study of Annamycin for Sarcoma Lung Metastases Dec 17, 2020
